Genocea Biosciences, Inc. (GNCA) Social Stream

Featured Post From StockTwits About GNCA

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend!

$GNCA
Market Price - $1.83
Average Hold - $2.86
Accumulate - Sub $1.65
Price Target - $3.25
Estimated Time Hold - 3Q
Support - $1.75, $2.50
Floor - $1.10
Double Down Target - Sub $1.25
Option - N/A
Micro DD - The TiTAN trial is an open-label, multi-center Phase1/2a trial evaluating safety, tolerability, T cell persistence and proliferation and clinical efficacy. Preliminary clinical response data from an initial subset of patients is expected in late Q4 2021 or Q1 2022. As of June 30, 2021, cash and cash equivalents were $60.4 million compared to $79.8 million as of December 31, 2020.